Glimitip MP 2mg/500mg/15mg Tablet
Marketer
Zodley Pharmaceuticals Pvt Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Glimitip MP 2mg/500mg/15mg Tablet
Glimitip MP, a 2mg/500mg/15mg tablet, combines medications to manage blood glucose in adults with type 2 diabetes. Used alongside diet and exercise, it enhances insulin effectiveness, reducing blood sugar. Follow your doctor's prescribed dosage and regimen; take it with food to minimize stomach discomfort. If a dose is missed, take it promptly unless the next dose is imminent; then, skip the missed dose. Never double the dose; overdose can cause dangerously low blood sugar (hypoglycemia). Concurrent use with other diabetes medications, alcohol, or skipped meals elevates hypoglycemia risk; regular blood sugar monitoring is crucial. Common side effects may include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Disclose any kidney, liver, or heart conditions before starting; pregnant or breastfeeding individuals should consult their physician. Kidney function tests are typically performed before treatment commences. Limit alcohol consumption to reduce potential side effects.
Primary Ingredients of Glimitip MP 2mg/500mg/15mg Tablet
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Glimitip MP 2mg/500mg/15mg Tablet
Managing type 2 diabetes
Major Benefits of Glimitip MP 2mg/500mg/15mg Tablet:
Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Glimitip MP 2mg/500mg/15mg Tablet should be administered with a meal.
Common Side effects of Glimitip MP 2mg/500mg/15mg Tablet:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glimitip MP 2mg/500mg/15mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Glimitip MP 2mg/500mg/15mg tablets with a meal.
How Glimitip MP 2mg/500mg/15mg Tablet works:
Glimitip MP 2mg/500mg/15mg tablets contain glimepiride, metformin, and pioglitazone—three antidiabetic agents with complementary actions. This triple combination effectively manages blood sugar levels when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release to reduce blood glucose. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity. Pioglitazone, a thiazolidinedione, further improves insulin responsiveness.
SAFETY ADVICE
AlcoholUNSAFE
Combining alcohol and Glimitip MP 2mg/500mg/15mg tablets poses a safety risk.
PregnancyCONSULT YOUR DOCTOR
The use of Glimitip MP 2mg/500mg/15mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Glimitip MP 2mg/500mg/15mg tablets while breastfeeding is likely inadvisable. Available human data indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Exercise caution when administering Glimitip MP 2mg/500mg/15mg tablets to individuals with impaired kidney function; dosage modification may be necessary. Consult a physician for guidance. The use of Glimitip MP 2mg/500mg/15mg tablets is contraindicated in patients exhibiting severe renal insufficiency. Routine monitoring of renal function is recommended during treatment.
LiverCAUTION
Individuals with liver impairment should exercise caution when using Glimitip MP 2mg/500mg/15mg tablets, as dose modification may be necessary. Medical advice is recommended. Glimitip MP 2mg/500mg/15mg tablets are contraindicated in patients with severe hepatic dysfunction.
What if you forget to take Glimitip MP 2mg/500mg/15mg Tablet :
Should you forget to take your Glimitip MP 2mg/500mg/15mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Glimitip MP 2mg/500mg/15mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently